THERMOGENESIS HOLDINGS INC (THMO) Fundamental Analysis & Valuation

NASDAQ:THMO • US88362L2097

Current stock price

0.3102 USD
-0.11 (-25.84%)
At close:
0.3161 USD
+0.01 (+1.9%)
After Hours:

This THMO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. THMO Profitability Analysis

1.1 Basic Checks

  • THMO had negative earnings in the past year.
  • THMO had a negative operating cash flow in the past year.
  • In the past 5 years THMO always reported negative net income.
  • THMO had a negative operating cash flow in each of the past 5 years.
THMO Yearly Net Income VS EBIT VS OCF VS FCFTHMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -146.23%, THMO is not doing good in the industry: 89.47% of the companies in the same industry are doing better.
  • THMO has a worse Return On Equity (-1512.82%) than 88.95% of its industry peers.
Industry RankSector Rank
ROA -146.23%
ROE -1512.82%
ROIC N/A
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
THMO Yearly ROA, ROE, ROICTHMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K -2K

1.3 Margins

  • THMO has a worse Gross Margin (21.18%) than 80.53% of its industry peers.
  • In the last couple of years the Gross Margin of THMO has declined.
  • THMO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
THMO Yearly Profit, Operating, Gross MarginsTHMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. THMO Health Analysis

2.1 Basic Checks

  • THMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, THMO has more shares outstanding
  • Compared to 1 year ago, THMO has a worse debt to assets ratio.
THMO Yearly Shares OutstandingTHMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
THMO Yearly Total Debt VS Total AssetsTHMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

  • Based on the Altman-Z score of -41.04, we must say that THMO is in the distress zone and has some risk of bankruptcy.
  • THMO's Altman-Z score of -41.04 is on the low side compared to the rest of the industry. THMO is outperformed by 93.68% of its industry peers.
  • A Debt/Equity ratio of 4.31 is on the high side and indicates that THMO has dependencies on debt financing.
  • The Debt to Equity ratio of THMO (4.31) is worse than 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Altman-Z -41.04
ROIC/WACCN/A
WACC17.38%
THMO Yearly LT Debt VS Equity VS FCFTHMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 0.52 indicates that THMO may have some problems paying its short term obligations.
  • With a Current ratio value of 0.52, THMO is not doing good in the industry: 96.84% of the companies in the same industry are doing better.
  • THMO has a Quick Ratio of 0.52. This is a bad value and indicates that THMO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • THMO's Quick ratio of 0.37 is on the low side compared to the rest of the industry. THMO is outperformed by 97.37% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.37
THMO Yearly Current Assets VS Current LiabilitesTHMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. THMO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 76.70% over the past year.
  • THMO shows a decrease in Revenue. In the last year, the revenue decreased by -7.66%.
  • Measured over the past years, THMO shows a decrease in Revenue. The Revenue has been decreasing by -0.47% on average per year.
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%

3.2 Future

  • Based on estimates for the next years, THMO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.39% on average per year.
  • THMO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.88% yearly.
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
THMO Yearly Revenue VS EstimatesTHMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M
THMO Yearly EPS VS EstimatesTHMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600 -800

More info and screens

Find the best growth stocksShow best growing peers

4

4. THMO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for THMO. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 1.52, which indicates a rather cheap valuation of THMO.
  • 100.00% of the companies in the same industry are more expensive than THMO, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of THMO to the average of the S&P500 Index (22.67), we can say THMO is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.52
THMO Price Earnings VS Forward Price EarningsTHMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
THMO Per share dataTHMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2 -3 -4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • THMO's earnings are expected to grow with 27.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.3%
EPS Next 3Y27.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. THMO Dividend Analysis

5.1 Amount

  • THMO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

THMO Fundamentals: All Metrics, Ratios and Statistics

THERMOGENESIS HOLDINGS INC

NASDAQ:THMO (6/14/2024, 8:00:01 PM)

After market: 0.3161 +0.01 (+1.9%)

0.3102

-0.11 (-25.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-17
Earnings (Next)08-08
Inst Owners0.02%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.47M
Revenue(TTM)9.60M
Net Income(TTM)-14.75M
Analysts82.86
Price Target5.1 (1544.1%)
Short Float %0.01%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-9460.78%
Min EPS beat(2)-14311.8%
Max EPS beat(2)-4609.8%
EPS beat(4)0
Avg EPS beat(4)-7128.85%
Min EPS beat(4)-14311.8%
Max EPS beat(4)-572.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.48%
Min Revenue beat(2)-33.57%
Max Revenue beat(2)-29.39%
Revenue beat(4)0
Avg Revenue beat(4)-36.28%
Min Revenue beat(4)-51.56%
Max Revenue beat(4)-29.39%
Revenue beat(8)0
Avg Revenue beat(8)-30.38%
Revenue beat(12)2
Avg Revenue beat(12)-26.36%
Revenue beat(16)2
Avg Revenue beat(16)-30.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.52
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B 2.53
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)-4.28
EYN/A
EPS(NY)0.2
Fwd EY65.76%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.45
OCFYN/A
SpS1.21
BVpS0.12
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -146.23%
ROE -1512.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.18%
FCFM N/A
ROA(3y)-91.09%
ROA(5y)-82.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.48%
GM growth 5Y-2.03%
F-Score3
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 4.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 81.17%
Cap/Sales 10.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.37
Altman-Z -41.04
F-Score3
WACC17.38%
ROIC/WACCN/A
Cap/Depr(3y)69.46%
Cap/Depr(5y)46.66%
Cap/Sales(3y)7.71%
Cap/Sales(5y)4.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)76.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15233.33%
EPS Next Y102.13%
EPS Next 2Y43.3%
EPS Next 3Y27.71%
EPS Next 5Y16.39%
Revenue 1Y (TTM)-7.66%
Revenue growth 3Y-1.02%
Revenue growth 5Y-0.47%
Sales Q2Q%6.42%
Revenue Next Year48.46%
Revenue Next 2Y36.17%
Revenue Next 3Y29.3%
Revenue Next 5Y20.88%
EBIT growth 1Y-0.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y47.2%
OCF growth 3YN/A
OCF growth 5YN/A

THERMOGENESIS HOLDINGS INC / THMO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of THERMOGENESIS HOLDINGS INC (THMO) stock?

ChartMill assigns a fundamental rating of 1 / 10 to THMO.


Can you provide the valuation status for THERMOGENESIS HOLDINGS INC?

ChartMill assigns a valuation rating of 4 / 10 to THERMOGENESIS HOLDINGS INC (THMO). This can be considered as Fairly Valued.


What is the profitability of THMO stock?

THERMOGENESIS HOLDINGS INC (THMO) has a profitability rating of 0 / 10.


What is the financial health of THERMOGENESIS HOLDINGS INC (THMO) stock?

The financial health rating of THERMOGENESIS HOLDINGS INC (THMO) is 0 / 10.